Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, Share and Forecast 2021-2027
The global
gastro esophageal reflux disease (GERD) drug market is anticipated to grow at a
CAGR of 2.3% during the forecast period. The major factor for the growth of the
market is the increasing disorders which are caused by GERD, as well as change
in lifestyle and unhealthy eating habits, which will fuel the growth of the
market during the forecast period.
There has been
increasing incidences of acidic taste in the mouth, heartburn, dry cough,
asthma, and many others, which will fuel the growth of the market during the
forecast period. The most commonly used drugs include NSAIDs, biphospohonates,
and potassium tablets for the treatment of the gastro esophageal reflux
disease. Antacids are the most used drug type for the treatment of the GERD,
antacids help in reducing stomach ache, heartburn, acid indigestion, and many
others. Antacid works directly by counteracting the acidity inside the
stomach by providing quick-relief to the patient. In 2019, antacid held the
market share of 49.9% across the globe to treat disorders caused by GERD. Some
of the antacids are Aluminium hydroxide gel, Calcium carbonate, Magnesium hydroxide,
Gelusil, Mylanta, Pepto-Bismol, and many others. In October 2020, Dr. Reddy’s
Laboratories launched a generic product in the US to treat GERD disorder like
the acid reflux; the tablets are called as famotidine, which areeffective
against heartburn, acid indigestion, sour stomach, and many others. Some of the
key global players in the thermal gap fillers market include Johnson and
Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer, Inc.,
Novartis AG, Eisai Co. Ltd., and many others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Gastro Esophageal Reflux Disease (GERD) Drug Market is
Available at: https://www.omrglobal.com/industry-reports/gastro-esophageal-reflux-disease-gerd-drug-market
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By
Drug Type
·
By
Application
·
Competitive Landscape -Johnson and Johnson, AstraZeneca PLC, Takeda
Pharmaceutical Company Limited, Pfizer, Inc., Novartis AG, Eisai Co.
Ltd., and many others.
Global gastro esophageal reflux disease (GERD)
drug market
o By
Type
·
Tablet
·
Chewable
·
Injectable
o By Application
·
Hospital
·
Laboratory
·
Others
Regional
Analysis
North
America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the
World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/gastro-esophageal-reflux-disease-gerd-drug-market
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment